Rezolute (RZLT) Research & Development (2010 - 2026)
Rezolute (RZLT) reported Research & Development of $11.4 million for Q1 2026, down 25.33% on a YoY basis from $15.3 million in Q1 2025, and down 20.46% sequentially from $14.3 million in Q4 2025.
Rezolute (RZLT) Research & Development (2010 - 2026) Analysis & Trends
Rezolute (RZLT) has 16 years of Research & Development data on file, last reported at $11.4 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 25.33% year-over-year to $11.4 million; the trailing twelve-month figure through Mar 2026 stood at $59.8 million (changed 0.03% YoY), and the FY2025 full-year result was $61.5 million, up 10.38% from the prior year.
- Research & Development declined to $11.4 million in Q1 2026, from $14.3 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $20.9 million in Q2 2025 to a low of $7.7 million in Q3 2022.
- A 5-year average of $12.8 million and a median of $12.4 million in 2024 frame the typical range for Research & Development.
- Across the five-year window, Research & Development jumped 131.13% in 2022 and decreased 25.33% in 2026, its largest moves.
- Tracing RZLT's Research & Development over 5 years: stood at $10.9 million in 2022, then increased by 10.0% to $12.0 million in 2023, then grew by 4.88% to $12.6 million in 2024, then grew by 13.63% to $14.3 million in 2025, then slipped by 20.46% to $11.4 million in 2026.
- Business Quant data shows RZLT's Research & Development at $11.4 million in Q1 2026, $14.3 million in Q4 2025, and $13.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Rezolute | 518.12 Mn | 518.12 Mn | - | 11.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.41 Mn |
| Dec 31, 2025 | 14.35 Mn |
| Sep 30, 2025 | 13.15 Mn |
| Jun 30, 2025 | 20.86 Mn |
| Mar 31, 2025 | 15.28 Mn |
| Dec 31, 2024 | 12.63 Mn |
| Sep 30, 2024 | 12.75 Mn |
| Jun 30, 2024 | 19.09 Mn |
| Mar 31, 2024 | 12.40 Mn |
| Dec 31, 2023 | 12.04 Mn |
| Sep 30, 2023 | 12.21 Mn |
| Jun 30, 2023 | 10.93 Mn |
| Mar 31, 2023 | 14.23 Mn |
| Dec 31, 2022 | 10.95 Mn |
| Sep 30, 2022 | 7.70 Mn |
| Jun 30, 2022 | 8.57 Mn |
| Mar 31, 2022 | 8.69 Mn |
| Dec 31, 2021 | 9.45 Mn |
| Sep 30, 2021 | 5.77 Mn |
| Jun 30, 2021 | 4.39 Mn |